NURIX THERAPEUTICS INC (NRIX) Stock Balance Sheet
NASDAQ:NRIX - Nasdaq - US67080M1036 - Common Stock - Currency: USD
| MRQ (2025-2-28) | 2024 (2024-11-30) | 2023 (2023-11-30) | 2022 (2022-11-30) | 2021 (2021-11-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 75.92M | 110.00M | 54.63M | 64.50M | 80.20M | |||
| Marketable Securities | 473.76M | 499.59M | 233.28M | 244.70M | 215.20M | |||
| Receivables | N/A | N/A | N/A | 0.00 | 6.20M | |||
| Other Current Assets | 14.02M | 9.80M | 7.59M | 9.30M | 9.50M | |||
| Total Current Assets | 563.70M | 619.39M | 295.50M | 318.40M | 311.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 44.81M | 45.90M | 47.95M | 29.50M | 25.30M | |||
| Investments And Advances | N/A | 0.00 | 7.42M | 63.90M | 137.20M | |||
| Other Non-Current Assets | 6.53M | 4.06M | 4.72M | 4.90M | 3.10M | |||
| Total Non-Current Assets | 51.34M | 49.96M | 60.09M | 98.40M | 165.70M | |||
| TOTAL ASSETS | 615.04M | 669.34M | 355.60M | 416.80M | 476.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 51.00M | 46.01M | 32.46M | 28.00M | 18.40M | |||
| Accounts Payable | 8.40M | 11.48M | 6.40M | 5.10M | 6.70M | |||
| Other Current Liabilities | 30.59M | 38.36M | 48.10M | 37.60M | 41.20M | |||
| Total Current Liabilities | 89.99M | 95.85M | 86.96M | 70.70M | 66.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 44.14M | 46.50M | 68.15M | 42.40M | 68.20M | |||
| Total Non-Current Liabilities | 44.14M | 46.50M | 68.15M | 42.40M | 68.20M | |||
| TOTAL LIABILITIES | 134.13M | 142.35M | 155.10M | 113.10M | 134.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -795.12M | -738.77M | -545.20M | -401.30M | -220.90M | |||
| Additional Paid In Capital | 1.28B | 1.27B | 746.30M | 709.20M | 563.80M | |||
| Common Shares | 76.00K | 76.00K | 49.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 226.00K | 150.00K | -655.00K | -4.30M | -600.00K | |||
| Shares Outstanding | 76.23M | 75.87M | 48.72M | 47.20M | 44.70M | |||
| Tangible Book Value per Share | 6.31 | 6.95 | 4.12 | 6.43 | 7.66 | |||
| Total Shareholders' Equity | 480.92M | 526.99M | 200.49M | 303.70M | 342.30M | |||
| TOTAL LIABILITIES AND EQUITY | 615.04M | 669.34M | 355.60M | 416.80M | 476.80M | |||
| Statistics | ||||||||
| Current Ratio | 6.26 | 6.46 | 3.40 | 4.50 | 4.69 | |||
| Return On Assets (ROA) | -33.88% | -28.92% | -40.48% | -43.27% | -24.58% | |||
| Return On Equity (ROE) | -43.33% | -36.73% | -71.80% | -59.39% | -34.24% | |||
All data in USD , ROIC based on taxRate of 0.21